QUALITY STATEMENT

Bone Solutions is committed to provide quality medical devices to the global medical device market-place that improve patient care, meet regulatory and customer requirements, while assuring the continual effectiveness and improvement of Bone Solutions’ Quality System.

News

  • 03/12/2019 to 03/16/2019 -Bone Solutions, Inc. will be attending the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting March 7-9 2018, in Las Vegas, NV. Please look for us at Booth 2567.
  • 02/26/2019 -Bone Solutions, Inc. reaches 500 implants of its proprietary magnesium-based bone void filler.
  • 03/07/2018 to 03/09/2018 -Bone Solutions, Inc. will be attending the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting March 7-9 2018, in New Orleans, LA. Please look for us at Booth 1714.
  • 01/23/2018 - Bone Solutions Inc. Reaches 50 Implants Of Its Proprietary Magnesium-Based Bone Void Filler
  • 09/28/2017 - Bone Solutions Inc. announces 1st implantation of OsteoCrete® Magnesium-based bone void filler.
  • 09/19/2017 - Bone Solutions Inc. Launches OsteoCrete® Magnesium-based bone void filler

ABOUT US

What Is Magnesium? Magnesium is a chemical element that’s found in abundance in the Earth’s crust. In its metallic form, magnesium is lightweight and strong, making it suitable for a wide range of industrial applications. Magnesium also plays a key role in human health and biology, and it is a natural nutrient essential for building healthy bones. Magnesium is an attractive orthopedic alternative because, unlike stainless steel or titanium, it is a biodegradable substance. The use of magnesium could conceivably eliminate the need for an invasive procedure to remove surgical hardware after the initial surgery.
Our vision is to create various classes of implants which incorporate Magnesium and are 100% resorbed and replaced by bone in the human body during the healing process. In 2017, the Company successfully launched OsteoCrete, a first-of-its-kind Magnesium based Bone Void Filler. The Company is now developing polymer-ceramic hybrid implants which we strongly believe will soon replace permanent metal alloys currently being used. These strong, tissue friendly, resorbable implants have mechanical properties similar to that of human bone, which eliminate the need for revisions, minimize stress fractures, and reduce the side effects of other non-degradable or biologically inert implants..

BOARD OF DIRECTORS

Leadership

Drew M. Diaz – CEO

  • Over 30 years of experience working in leadership positions in healthcare and the medical device arena
  • Cofounded a US based medical device company
  • Held senior roles in medical device companies domestically and internationally
  • Has lived and worked in four different countries during his life and career
  • Managed offices in Brazil, Germany, India, China, and the United States

Brandon Roller MD, PhD – CTO

  • Medical Doctorate -University of Missouri-Columbia
  • Resident - Wake Forest Baptist Medical Center
  • Arthrex® Product Development (former)

Frankie L Morris – DIRECTOR OF ENGINEERING AND OPERATIONS

  • Over fifteen years in product development & ten years engineering project management.
  • Ten medical device patents & four pending in the United States (USPTO)
  • Over 15 medical devices in the market today which include ten different FDA 510K medical device clearances.
  • Studied Engineering at University of Toledo, Indiana State University and Technical Management at American University.

Clinical Advisors

JOSEPH P. IANNOTTI, MD

  • Chief of Staff for Cleveland Clinic Florida Region
  • Chairman of the Orthropaedic and Rheumatology Institute at the Cleveland Clinic
  • Professor of Orthopaedic Surgery at University of Pennsylvania (former)

NED AMENDOLA, MD

  • Chief Medical Officer at Duke Health System
  • Director and Member of Integrative Performance Excellence Group at Duke University

BRANDON ROLLER, MD, PHD

  • Medical Doctorate -University of Missouri-Columbia
  • Resident - Wake Forest Baptist Medical Center
  • Arthrex® Product Development (former)

FRANCIS HORNICEK, MD, PHD

  • Professor and Chair, Department of Orthopedic Surgery UCLA Medical Center, Santa Monica
  • Former Chief of the Orthopedic Oncology Service at Massachusetts General Hospital (MGH)
  • Professor of Orthopedic Surgery at Harvard Medical School
  • Director MGH Stephan L. Harris Chordoma Center

STEPHEN SCHENDEL, MD

  • Professor of Surgery Emeritus at Stanford University Medical Center
  • Director of the California Craniofacial Institute

GARY PERLMUTTER, MD

  • Orthopedic Shoulder Surgeon, Massachusetts General Hospital
  • Clinical Instructor, Orthopedic Surgery, Harvard Medical School

PRODUCTS

Resources

RESEARCH PAPERS

*All studies summaries are available upon request through customer service.

SYMBOLS GLOSSARY

Careers

Currently, there are no Openings available.

Company Policy/Procedural Compliance
Follow all company policies and procedures as well as local, state and federal laws concerning employment to include, but not limited to: I-9 information, EEOC, Civil Rights and ADA.

DISTRIBUTORSHIPS

BSI is actively seeking highly motivated distributors. We value our distributors and view distributors as strategic partners.

For more information on becoming a distributor please contact us today.

Company Policy/Procedural Compliance
Follow all company policies and procedures as well as local, state and federal laws concerning employment to include, but not limited to: I-9 information, EEOC, Civil Rights and ADA.

News

Contact us

BONE SOLUTIONS INC.

5712 COLLEYVILLE BLVD., SUITE 210
COLLEYVILLE, TEXAS 76034

Phone: 817.809.8850
Email: customerservice@bonesolutions.net